Global Liver Cancer Therapeutics Market Growth (Status and Outlook) 2025-2031

September 2025 | 82 pages | ID: G145509A02E0EN
LP Information

Abstracts

According to this study, the global Liver Cancer Therapeutics market size will reach US$ million by 2031.

Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Liver Cancer Therapeutics Industry Forecast” looks at past sales and reviews total world Liver Cancer Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Liver Cancer Therapeutics sales for 2025 through 2031. With Liver Cancer Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liver Cancer Therapeutics industry.

This Insight Report provides a comprehensive analysis of the global Liver Cancer Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Liver Cancer Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liver Cancer Therapeutics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liver Cancer Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liver Cancer Therapeutics.

This report presents a comprehensive overview, market shares, and growth opportunities of Liver Cancer Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Targeted Therapy
• Radiation Therapy
• Immunotherapy
• Chemotherapy
• Other

Segmentation by Application:

• Hepatocellular Carcinoma
• Cholangio Carcinoma
• Hepatoblastoma
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ArQule
• Bayer
• Bristol-Myers Squibb
• Celsion
• Eisai
• Exelixis
• Roche
• Merck
• Pfizer
• IntegraGen

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Liver Cancer Therapeutics Market Size (2020-2031)
  2.1.2 Liver Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Liver Cancer Therapeutics by Country/Region (2020, 2024 & 2031)
2.2 Liver Cancer Therapeutics Segment by Type
  2.2.1 Targeted Therapy
  2.2.2 Radiation Therapy
  2.2.3 Immunotherapy
  2.2.4 Chemotherapy
  2.2.5 Other
2.3 Liver Cancer Therapeutics Market Size by Type
  2.3.1 Liver Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
2.4 Liver Cancer Therapeutics Segment by Application
  2.4.1 Hepatocellular Carcinoma
  2.4.2 Cholangio Carcinoma
  2.4.3 Hepatoblastoma
  2.4.4 Other
2.5 Liver Cancer Therapeutics Market Size by Application
  2.5.1 Liver Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)

3 LIVER CANCER THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Liver Cancer Therapeutics Market Size Market Share by Player
  3.1.1 Global Liver Cancer Therapeutics Revenue by Player (2020-2025)
  3.1.2 Global Liver Cancer Therapeutics Revenue Market Share by Player (2020-2025)
3.2 Global Liver Cancer Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LIVER CANCER THERAPEUTICS BY REGION

4.1 Liver Cancer Therapeutics Market Size by Region (2020-2025)
4.2 Global Liver Cancer Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Liver Cancer Therapeutics Market Size Growth (2020-2025)
4.4 APAC Liver Cancer Therapeutics Market Size Growth (2020-2025)
4.5 Europe Liver Cancer Therapeutics Market Size Growth (2020-2025)
4.6 Middle East & Africa Liver Cancer Therapeutics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Liver Cancer Therapeutics Market Size by Country (2020-2025)
5.2 Americas Liver Cancer Therapeutics Market Size by Type (2020-2025)
5.3 Americas Liver Cancer Therapeutics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Liver Cancer Therapeutics Market Size by Region (2020-2025)
6.2 APAC Liver Cancer Therapeutics Market Size by Type (2020-2025)
6.3 APAC Liver Cancer Therapeutics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Liver Cancer Therapeutics Market Size by Country (2020-2025)
7.2 Europe Liver Cancer Therapeutics Market Size by Type (2020-2025)
7.3 Europe Liver Cancer Therapeutics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Liver Cancer Therapeutics by Region (2020-2025)
8.2 Middle East & Africa Liver Cancer Therapeutics Market Size by Type (2020-2025)
8.3 Middle East & Africa Liver Cancer Therapeutics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LIVER CANCER THERAPEUTICS MARKET FORECAST

10.1 Global Liver Cancer Therapeutics Forecast by Region (2026-2031)
  10.1.1 Global Liver Cancer Therapeutics Forecast by Region (2026-2031)
  10.1.2 Americas Liver Cancer Therapeutics Forecast
  10.1.3 APAC Liver Cancer Therapeutics Forecast
  10.1.4 Europe Liver Cancer Therapeutics Forecast
  10.1.5 Middle East & Africa Liver Cancer Therapeutics Forecast
10.2 Americas Liver Cancer Therapeutics Forecast by Country (2026-2031)
  10.2.1 United States Market Liver Cancer Therapeutics Forecast
  10.2.2 Canada Market Liver Cancer Therapeutics Forecast
  10.2.3 Mexico Market Liver Cancer Therapeutics Forecast
  10.2.4 Brazil Market Liver Cancer Therapeutics Forecast
10.3 APAC Liver Cancer Therapeutics Forecast by Region (2026-2031)
  10.3.1 China Liver Cancer Therapeutics Market Forecast
  10.3.2 Japan Market Liver Cancer Therapeutics Forecast
  10.3.3 Korea Market Liver Cancer Therapeutics Forecast
  10.3.4 Southeast Asia Market Liver Cancer Therapeutics Forecast
  10.3.5 India Market Liver Cancer Therapeutics Forecast
  10.3.6 Australia Market Liver Cancer Therapeutics Forecast
10.4 Europe Liver Cancer Therapeutics Forecast by Country (2026-2031)
  10.4.1 Germany Market Liver Cancer Therapeutics Forecast
  10.4.2 France Market Liver Cancer Therapeutics Forecast
  10.4.3 UK Market Liver Cancer Therapeutics Forecast
  10.4.4 Italy Market Liver Cancer Therapeutics Forecast
  10.4.5 Russia Market Liver Cancer Therapeutics Forecast
10.5 Middle East & Africa Liver Cancer Therapeutics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Liver Cancer Therapeutics Forecast
  10.5.2 South Africa Market Liver Cancer Therapeutics Forecast
  10.5.3 Israel Market Liver Cancer Therapeutics Forecast
  10.5.4 Turkey Market Liver Cancer Therapeutics Forecast
10.6 Global Liver Cancer Therapeutics Forecast by Type (2026-2031)
10.7 Global Liver Cancer Therapeutics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Liver Cancer Therapeutics Forecast

11 KEY PLAYERS ANALYSIS

11.1 ArQule
  11.1.1 ArQule Company Information
  11.1.2 ArQule Liver Cancer Therapeutics Product Offered
  11.1.3 ArQule Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 ArQule Main Business Overview
  11.1.5 ArQule Latest Developments
11.2 Bayer
  11.2.1 Bayer Company Information
  11.2.2 Bayer Liver Cancer Therapeutics Product Offered
  11.2.3 Bayer Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer Main Business Overview
  11.2.5 Bayer Latest Developments
11.3 Bristol-Myers Squibb
  11.3.1 Bristol-Myers Squibb Company Information
  11.3.2 Bristol-Myers Squibb Liver Cancer Therapeutics Product Offered
  11.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myers Squibb Main Business Overview
  11.3.5 Bristol-Myers Squibb Latest Developments
11.4 Celsion
  11.4.1 Celsion Company Information
  11.4.2 Celsion Liver Cancer Therapeutics Product Offered
  11.4.3 Celsion Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Celsion Main Business Overview
  11.4.5 Celsion Latest Developments
11.5 Eisai
  11.5.1 Eisai Company Information
  11.5.2 Eisai Liver Cancer Therapeutics Product Offered
  11.5.3 Eisai Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Eisai Main Business Overview
  11.5.5 Eisai Latest Developments
11.6 Exelixis
  11.6.1 Exelixis Company Information
  11.6.2 Exelixis Liver Cancer Therapeutics Product Offered
  11.6.3 Exelixis Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Exelixis Main Business Overview
  11.6.5 Exelixis Latest Developments
11.7 Roche
  11.7.1 Roche Company Information
  11.7.2 Roche Liver Cancer Therapeutics Product Offered
  11.7.3 Roche Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Roche Main Business Overview
  11.7.5 Roche Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Liver Cancer Therapeutics Product Offered
  11.8.3 Merck Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Liver Cancer Therapeutics Product Offered
  11.9.3 Pfizer Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 IntegraGen
  11.10.1 IntegraGen Company Information
  11.10.2 IntegraGen Liver Cancer Therapeutics Product Offered
  11.10.3 IntegraGen Liver Cancer Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 IntegraGen Main Business Overview
  11.10.5 IntegraGen Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Liver Cancer Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Liver Cancer Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Radiation Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Chemotherapy
Table 7. Major Players of Other
Table 8. Liver Cancer Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Liver Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Table 11. Liver Cancer Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Liver Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Table 14. Global Liver Cancer Therapeutics Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Liver Cancer Therapeutics Revenue Market Share by Player (2020-2025)
Table 16. Liver Cancer Therapeutics Key Players Head office and Products Offered
Table 17. Liver Cancer Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Liver Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Liver Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Table 22. Global Liver Cancer Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Liver Cancer Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Liver Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Liver Cancer Therapeutics Market Size Market Share by Country (2020-2025)
Table 26. Americas Liver Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Table 28. Americas Liver Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Table 30. APAC Liver Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Liver Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Table 32. APAC Liver Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Liver Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Liver Cancer Therapeutics Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Liver Cancer Therapeutics Market Size Market Share by Country (2020-2025)
Table 36. Europe Liver Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Liver Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Liver Cancer Therapeutics Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Liver Cancer Therapeutics Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Liver Cancer Therapeutics Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Liver Cancer Therapeutics
Table 42. Key Market Challenges & Risks of Liver Cancer Therapeutics
Table 43. Key Industry Trends of Liver Cancer Therapeutics
Table 44. Global Liver Cancer Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Liver Cancer Therapeutics Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Liver Cancer Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Liver Cancer Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. ArQule Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 49. ArQule Liver Cancer Therapeutics Product Offered
Table 50. ArQule Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. ArQule Main Business
Table 52. ArQule Latest Developments
Table 53. Bayer Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 54. Bayer Liver Cancer Therapeutics Product Offered
Table 55. Bayer Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Bristol-Myers Squibb Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 59. Bristol-Myers Squibb Liver Cancer Therapeutics Product Offered
Table 60. Bristol-Myers Squibb Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Bristol-Myers Squibb Main Business
Table 62. Bristol-Myers Squibb Latest Developments
Table 63. Celsion Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 64. Celsion Liver Cancer Therapeutics Product Offered
Table 65. Celsion Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Celsion Main Business
Table 67. Celsion Latest Developments
Table 68. Eisai Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 69. Eisai Liver Cancer Therapeutics Product Offered
Table 70. Eisai Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Eisai Main Business
Table 72. Eisai Latest Developments
Table 73. Exelixis Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 74. Exelixis Liver Cancer Therapeutics Product Offered
Table 75. Exelixis Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Exelixis Main Business
Table 77. Exelixis Latest Developments
Table 78. Roche Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 79. Roche Liver Cancer Therapeutics Product Offered
Table 80. Roche Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Roche Main Business
Table 82. Roche Latest Developments
Table 83. Merck Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 84. Merck Liver Cancer Therapeutics Product Offered
Table 85. Merck Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Pfizer Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 89. Pfizer Liver Cancer Therapeutics Product Offered
Table 90. Pfizer Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. IntegraGen Details, Company Type, Liver Cancer Therapeutics Area Served and Its Competitors
Table 94. IntegraGen Liver Cancer Therapeutics Product Offered
Table 95. IntegraGen Liver Cancer Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. IntegraGen Main Business
Table 97. IntegraGen Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Liver Cancer Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Liver Cancer Therapeutics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Liver Cancer Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Liver Cancer Therapeutics Sales Market Share by Country/Region (2024)
Figure 8. Liver Cancer Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Liver Cancer Therapeutics Market Size Market Share by Type in 2024
Figure 10. Liver Cancer Therapeutics in Hepatocellular Carcinoma
Figure 11. Global Liver Cancer Therapeutics Market: Hepatocellular Carcinoma (2020-2025) & ($ millions)
Figure 12. Liver Cancer Therapeutics in Cholangio Carcinoma
Figure 13. Global Liver Cancer Therapeutics Market: Cholangio Carcinoma (2020-2025) & ($ millions)
Figure 14. Liver Cancer Therapeutics in Hepatoblastoma
Figure 15. Global Liver Cancer Therapeutics Market: Hepatoblastoma (2020-2025) & ($ millions)
Figure 16. Liver Cancer Therapeutics in Other
Figure 17. Global Liver Cancer Therapeutics Market: Other (2020-2025) & ($ millions)
Figure 18. Global Liver Cancer Therapeutics Market Size Market Share by Application in 2024
Figure 19. Global Liver Cancer Therapeutics Revenue Market Share by Player in 2024
Figure 20. Global Liver Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Figure 21. Americas Liver Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 22. APAC Liver Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 23. Europe Liver Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Liver Cancer Therapeutics Market Size 2020-2025 ($ millions)
Figure 25. Americas Liver Cancer Therapeutics Value Market Share by Country in 2024
Figure 26. United States Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Liver Cancer Therapeutics Market Size Market Share by Region in 2024
Figure 31. APAC Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 32. APAC Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 33. China Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 37. India Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Liver Cancer Therapeutics Market Size Market Share by Country in 2024
Figure 40. Europe Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 41. Europe Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 42. Germany Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 43. France Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Liver Cancer Therapeutics Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Liver Cancer Therapeutics Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Liver Cancer Therapeutics Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Liver Cancer Therapeutics Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 56. APAC Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 57. Europe Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 59. United States Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 60. Canada Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 61. Mexico Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 62. Brazil Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 63. China Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 64. Japan Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 65. Korea Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 67. India Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 68. Australia Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 69. Germany Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 70. France Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 71. UK Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 72. Italy Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 73. Russia Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 74. Egypt Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 75. South Africa Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 76. Israel Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 77. Turkey Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)
Figure 78. Global Liver Cancer Therapeutics Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Liver Cancer Therapeutics Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Liver Cancer Therapeutics Market Size 2026-2031 ($ millions)